Compounds > selegiline
Page last updated: 2024-08-23

selegiline and n-(2-aminoethyl)-4-chlorobenzamide hydrochloride

selegiline has been researched along with n-(2-aminoethyl)-4-chlorobenzamide hydrochloride in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19904 (66.67)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arnolde, SM; Cordi, AA; Handelmann, GE; Mueller, LL; Nevins, ME1
Bonetti, EP; Da Prada, M; Imhof, R; Keller, HH; Kettler, R1
Dostert, P; Strolin Benedetti, M1
Cesura, AM; Da Prada, M; Galva, MD; Imhof, R; Picotti, GB; Takacs, B1
Bondiolotti, GP; Galva, MD; Picotti, GB; Sciaba, L; Villa, F1
He, XJ; Nakayama, H; Uetsuka, K1

Reviews

1 review(s) available for selegiline and n-(2-aminoethyl)-4-chlorobenzamide hydrochloride

ArticleYear
Overview of the present state of MAO inhibitors.
    Journal of neural transmission. Supplementum, 1987, Volume: 23

    Topics: Animals; Benzamides; Humans; Hydrazines; Isoquinolines; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Parkinson Disease; Phenethylamines; Piperidines; Selegiline; Structure-Activity Relationship

1987

Other Studies

5 other study(ies) available for selegiline and n-(2-aminoethyl)-4-chlorobenzamide hydrochloride

ArticleYear
Milacemide, a glycine prodrug, enhances performance of learning tasks in normal and amnestic rodents.
    Pharmacology, biochemistry, and behavior, 1989, Volume: 34, Issue:4

    Topics: Acetamides; Amnesia; Animals; Avoidance Learning; Benzamides; Exploratory Behavior; Glycine; Male; Mice; Monoamine Oxidase Inhibitors; Prodrugs; Rats; Selegiline

1989
Ro 16-6491: a new reversible and highly selective MAO-B inhibitor protects mice from the dopaminergic neurotoxicity of MPTP.
    Advances in neurology, 1987, Volume: 45

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzamides; Brain; Corpus Striatum; Dopamine; Male; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurotransmitter Agents; Parkinson Disease, Secondary; Pyridines; Rats; Selegiline; Substantia Nigra; Tyramine

1987
[3H]Ro 16-6491, a selective probe for affinity labelling of monoamine oxidase type B in human brain and platelet membranes.
    Journal of neurochemistry, 1988, Volume: 50, Issue:4

    Topics: Affinity Labels; Benzamides; Binding Sites; Blood Platelets; Borohydrides; Brain; Cell Membrane; Chromatography, High Pressure Liquid; Electrophoresis, Polyacrylamide Gel; Humans; Hydrogen-Ion Concentration; Molecular Weight; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; Selegiline; Tritium

1988
In vitro effects on monoamine uptake and release by the reversible monoamine oxidase-B inhibitors lazabemide and N-(2-aminoethyl)-p-chlorobenzamide: a comparison with L-deprenyl.
    Biochemical pharmacology, 1995, Jun-29, Volume: 50, Issue:1

    Topics: Animals; Benzamides; Biogenic Monoamines; Blood Platelets; Male; Monoamine Oxidase Inhibitors; Picolinic Acids; Rats; Rats, Sprague-Dawley; Selegiline; Serotonin; Synaptosomes

1995
Neural progenitor cells are protected against MPTP by MAO-B inhibitors.
    Neurotoxicology, 2008, Volume: 29, Issue:6

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adult Stem Cells; Age Factors; Animals; Animals, Newborn; Apoptosis; Benzamides; Cell Count; Cerebral Ventricles; In Situ Nick-End Labeling; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Neurons; Neurotoxins; Selegiline; Tyrosine 3-Monooxygenase

2008